Your browser doesn't support javascript.
loading
Cutaneous leishmaniasis responds to daylight-activated photodynamic therapy: proof of concept for a novel self-administered therapeutic modality.
Enk, C D; Nasereddin, A; Alper, R; Dan-Goor, M; Jaffe, C L; Wulf, H C.
Afiliação
  • Enk CD; Department of Dermatology, Hadassah Medical Organization, The Hebrew University Medical School, Jerusalem, Israel.
  • Nasereddin A; Department of Microbiology and Molecular Genetics, IMRIC, Kuvin Centre for the Study of Infectious and Tropical Diseases, Hadassah Medical School, Hebrew University, Jerusalem, Israel.
  • Alper R; Department of Dermatology, Hadassah Medical Organization, The Hebrew University Medical School, Jerusalem, Israel.
  • Dan-Goor M; Department of Microbiology and Molecular Genetics, IMRIC, Kuvin Centre for the Study of Infectious and Tropical Diseases, Hadassah Medical School, Hebrew University, Jerusalem, Israel.
  • Jaffe CL; Department of Microbiology and Molecular Genetics, IMRIC, Kuvin Centre for the Study of Infectious and Tropical Diseases, Hadassah Medical School, Hebrew University, Jerusalem, Israel.
  • Wulf HC; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Br J Dermatol ; 172(5): 1364-70, 2015.
Article em En | MEDLINE | ID: mdl-25363817
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Leishmaniose Cutânea / Helioterapia Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Leishmaniose Cutânea / Helioterapia Idioma: En Ano de publicação: 2015 Tipo de documento: Article